HC Deb 30 April 2002 vol 384 c730W
Tony Baldry

To ask the Chancellor of the Exchequer which companies will be expected to receive tax relief on(a) research and development into vaccines and medicines for the prevention and treatment of malaria, TB and those strains of AIDS which predominantly affect people in developing countries and (b) responsible donations of medical supplies and equipment to support developing countries' own health strategies and the needs of their people. [53117]

Dawn Primarolo

Any company that meets the requirements of the legislation to be introduced in the current Finance Bill can benefit from the measures. Details of claims by individual taxpayers are confidential.